Anne Douar, Chief Development Officer of Vivet Therapeutics
Vivet Therapeutics will be at the upcoming European Society of Gene And Cell Therapy (ESGCT) 26th annual congress in Lausanne…
Vivet Therapeutics CEO, Jean-Philippe Combal, will be presenting and hosting 1x1 meetings during Chardan Gene Therapy conference in New York on October…
Vivet Therapeutics' CEO, Jean-Philippe Combal
Vivet Therapeutics announces different presentations
Vivet Therapeutics' CEO, Jean-Philippe Combal
Vivet's CEO, Jean-Philippe Combal and Thomas Daniel, BD Director, will be hosting 1x1 meetings during BIO 2018 in Boston on June 4-7.
Vivet Therapeutics announces 2 presentations on its lead product
Vivet Therapeutics' CEO, Jean-Philippe Combal